Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: A cohort study

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Fournier, Jean Pascal ^a,b   Lapeyre Mestre, Maryse ^a,b,c   Sommet, Agnès ^a,b,c   Dupouy, Julie ^a,b   Poutrain, Jean Christophe ^a   Montastruc, Jean Louis ^a,b,c  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b INSERM   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; ALMINOPROFEN; ANGIOTENSIN RECEPTOR ANTAGONIST; CELECOXIB; CREATININE; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; MELOXICAM; MORNIFLUMATE; NABUMETONE; NAPROXEN; NIFLUMIC ACID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; POTASSIUM; SULINDAC; TENOXICAM; TIAPROFENIC ACID; UNINDEXED DRUG; ANTIHYPERTENSIVE AGENT;

AGE; ANESTHESIST; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOLOGIST; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EXPOSURE; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PHARMACOEPIDEMIOLOGY; POTASSIUM BLOOD LEVEL; PRESCRIPTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; AGED; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL PRACTICE; DRUG INTERACTION; FRANCE; HYPERKALEMIA; INSURANCE; KIDNEY FAILURE; MIDDLE AGED; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; CREATININE; DIURETICS; DRUG INTERACTIONS; FEMALE; FRANCE; HUMANS; HYPERKALEMIA; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POTASSIUM; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858973666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034187     Document Type: Article

References (25)

1. Olyaei AJ, Whelton A, Sturmer T, Porter GA, (2008) Non-steroidal anti-inflammatory drugs. In: de Broe ME, Porter GA, editors. Clinical Nephrotoxins: Renal injury from drugs and chemicals, 3rd ed pp. 419-457.
2. Loboz KK, Shenfield GM, (2005) Drug combinations and impaired renal function - the "triple whammy." Br J Clin Pharmacol 59: 239-243.
3. Saint-Salvi B, Hueber S, De Roef P, (2009) Thesaurus des interactions médicamenteuses. Available:http://www.afssaps.fr/Dossiers-thematiques/Interactions-medicamenteuses/Interactions-medicamenteuses/%28offset%29/0. Accessed 15 Dec 2011.
4. Vidal (2011) Vidal 2011: Le Dictionnaire. 87th ed Paris O.V.P. eds.
5. Revue Prescrire (2009) Éviter les effets indésirables par interactions médicamenteuses- Le Guide Prescrire Édition 2010. Rev Prescrire 29: 50-63.
6. Martin-Latry K, Bégaud B, (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 19: 256-265.
7. WHO Collaborating Centre for Drug Statistics Methodology (n.d.) ATC/DDD Index. Available:http://www.whocc.no/atc_ddd_index/. Accessed 2011 Dec 15.
8. Bootsma JEM, Warlé-van Herwaarden MF, Verbeek ALM, Füssenich P, De Smet PAGM, et al. (2011) Adherence to biochemical monitoring recommendations in patients starting with Renin Angiotensin system inhibitors: a retrospective cohort study in the Netherlands. Drug Saf 34: 605-614.
9. Lugardon S, Roussel H, Bourrel R, Sciortino V, Montastruc J-L, et al. (2006) Patterns of non steroidal anti-inflammatory drug use in ambulatory care. Therapie 61: 109-114.
10. Clinard F, Sgro C, Bardou M, Dumas M, Hillon P, et al. (2001) Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Pharmacoepidemiol Drug Saf 10: 329-338.
11. Haute Autorité de Santé (2009) Brexin, cycladol, feldene, proxalyoc (piroxicam), anti-inflammatoire non stéroïdien. Available:http://www.has-sante.fr/portail/jcms/c_834675/brexin-cycladol-feldene-proxalyoc-piroxicam-anti-inflammatoire-non-steroidien. Accessed 2011 Dec 15.
12. Hargreaves K, Abbott PV, (2005) Drugs for pain management in dentistry. Aust Dent J 50: S14-S22.
13. McGettigan P, Henry D, (2011) Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 8: e1001098.
14. McDowell SE, Ferner RE, (2011) Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic review. Drug Saf 34: 1049-1059.
15. Mikhail SS, Zwar NA, Vagholkar S, Dennis SM, Day RO, (2007) Non-steroidal anti-inflammatory drugs in general practice: a decision-making dilemma. Med J Aust 187: 160-163.
16. Langley C, Faulkner A, Watkins C, Gray S, Harvey I, (1998) Use of guidelines in primary care-practitioners' perspectives. Fam Pract 15: 105-111.
17. Schedlbauer A, Prasad V, Mulvaney C, Phansalkar S, Stanton W, et al. (2009) What Evidence Supports the Use of Computerized Alerts and Prompts to Improve Clinicians' Prescribing Behavior? J Am Med Inform Assoc 16: 531-538.
18. British Medical Association, Royal Pharmaceutical Society of Great Britain (2011) British National Formulary 62 London.
19. Vitry AI, (2007) Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 63: 709-714.
20. Goldman RE, Soran CS, Hayward GL, Simon SR, (2010) Doctors' perceptions of laboratory monitoring in office practice. J Eval Clin Pract 16: 1136-1141.
21. Weingart SN, Seger AC, Feola N, Heffernan J, Schiff G, et al. (2011) Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel. Drug Saf 34: 587-593.
22. Brochier ML, (1993) Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial. Eur Heart J 14: 951-957.
23. Brefel-Courbon C, Grolleau S, Thalamas C, Bourrel R, Allaria-Lapierre V, et al. (2009) Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population. Pain 141: 14-18.
24. Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, et al. (2007) Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf 16: 55-64.
25. Holdgate A, Pollock T, (2004) Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ 328: 1401-1401.